It's that the pharmacokinetic path from muscle to skin dermis wastes the majority of dosed peptide on systemic distribution that contributes nothing to cosmetic endpoints
Published: September 1, 2021 Footnotes Supplemental information can be found online at Supplemental information Data and code availability Original data may be reviewed consistent with conditions within the informed consent signed by participants in the PIONEER and SUSTAIN clinical trial programs, upon contacting the authors, upon request to the lead contact, Daniel Drucker
He has posted studies on this several times, ill see of o can get him to come here and answer
Endocrine markers Baseline concentrations of the endocrine markers at T1 were not significantly different across the four conditions ( p s 0.05, Table S2)
GLP-1 medicines can cause significant side effects
Even as the shortage ends, patients might still prefer to buy compounded medication because these are the only affordable treatment options for type 2 diabetes treatment and weight loss
/assets/images/provider/photos/2775923.jpeg)
